Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Rossari Biotech LtdIndustry : Chemicals
BSE Code:543213NSE Symbol: ROSSARIP/E(TTM):32.19
ISIN Demat:INE02A801020Div & Yield %:0.07EPS(TTM):20.73
Book Value(Rs):194.562771Market Cap ( Cr.):3693.87Face Value(Rs):2
    Change Company 
Date Headline
06-May-25 Rossari Biotech Ltd - Rossari Biotech Limited - Resignation
29-Apr-25 Rossari Biotech Ltd - Rossari Biotech Limited - Analysts/Institutional Investor Meet/Con. Call Updates
28-Apr-25 Rossari Biotech Q4 PAT rises to Rs34 crore in FY25
28-Apr-25 Rossari Biotech Ltd - Rossari Biotech Limited - Other General Purpose
26-Apr-25 Board of Rossari Biotech recommends final dividend
26-Apr-25 Rossari Biotech consolidated net profit rises 0.91% in the March 2025 quarter
26-Apr-25 Rossari Biotech standalone net profit rises 23.65% in the March 2025 quarter
25-Apr-25 Rossari Biotech Ltd - Corporate Action-Board approves Dividend
25-Apr-25 Rossari Biotech Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On April 25 2025.
25-Apr-25 Rossari Biotech Ltd - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended M..
<< < 1 2 3 4   > >>